Drug search by name

Prograf (Tacrolimus Injection) and QT interval prolongation

Result of checking the interaction of drug Prograf (Tacrolimus Injection) and disease QT interval prolongation for safety when used together.

Check result:

Prograf (Tacrolimus Injection) <> QT interval prolongation

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Tacrolimus may prolong the QT/QTc interval and may cause Torsade de Pointes. It is recommended to avoid tacrolimus in patients with congenital long QT syndrome. In patients with congestive heart failure, bradyarrhythmias, those taking certain antiarrhythmic medications or other medicinal products that lead to QT prolongation, and those with electrolyte disturbances such as hypokalemia, hypocalcemia, or hypomagnesemia, consider monitoring of tacrolimus whole blood concentrations and obtaining electrocardiograms and monitoring electrolytes (magnesium, potassium, calcium) periodically during treatment.

Prograf (Tacrolimus Injection)

Generic Name: tacrolimus

Brand Name: Prograf, Astagraf XL, Envarsus XR, Hecoria

Synonyms: Prograf

What is Prograf (Tacrolimus Injection)?